11β-hydroxylase deficiency screening: Difference between revisions
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{Ammu}} | {{CMG}}; {{AE}} {{Ammu}} | ||
==Overview== | ==Overview== | ||
Prenatal screening for congenital adrenal hyperplasia due to 11β-hydroxylase deficiency, by an 11-deoxycortisol injection into the [[amniotic fluid]], is recommended among patients with suspected congenital adrenal hyperplasia due to 11β-hydroxylase deficiency<ref name="w"> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> | Prenatal screening for congenital adrenal hyperplasia due to 11β-hydroxylase deficiency, by an 11-deoxycortisol injection into the [[amniotic fluid]], is recommended among patients with suspected congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.<ref name="w"> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> | ||
==Screening== | ==Screening== | ||
Injecting a dose of 11-deoxycortisol into the [[amniotic fluid]] helps in prenatal screening of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.<ref name="w"> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> | Injecting a dose of 11-deoxycortisol into the [[amniotic fluid]] helps in prenatal screening of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.<ref name="w"> Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016</ref> | ||
Revision as of 16:58, 9 February 2016
|
Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency Microchapters |
|
Differentiating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
11β-hydroxylase deficiency screening On the Web |
|
American Roentgen Ray Society Images of 11β-hydroxylase deficiency screening |
|
Directions to Hospitals Treating Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency |
|
Risk calculators and risk factors for 11β-hydroxylase deficiency screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Prenatal screening for congenital adrenal hyperplasia due to 11β-hydroxylase deficiency, by an 11-deoxycortisol injection into the amniotic fluid, is recommended among patients with suspected congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.[1]
Screening
Injecting a dose of 11-deoxycortisol into the amniotic fluid helps in prenatal screening of congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.[1]
References
- ↑ 1.0 1.1 Congenital adrenal hyperplasia due to 11β-hydroxylase deficiency. Wikipedia (2016). https://en.wikipedia.org/wiki/Congenital_adrenal_hyperplasia_due_to_11%CE%B2-hydroxylase_deficiency Accessed on January 29, 2016